Nothing like some free advertising for Robing Young. March 1, 2011
commemorates the 6th annual Stem Cell Lalapalooza in NYC. Unfortunately this venue is not Ozzfest with bands like Kataklysm, California Wildebeest, or Devil Driver, but it has been know to resemble a Motley Crue. Concert Promoter Robin Young is expecting an SRO crowd for this event and has his elves working feverishly. The show will take place at the infamous Bridgewaters New York, in the bowels of the South Street Seaport, New York City, New York. Why not the Hammerstein Ballroom? Whether you are a skeptic or zealot, stem cells have taken front and center stage in the field of biologic's. There are an endless list of applications that researchers are studying. Baldness, blindness, traumatic brain injuries, parkinson's disease, dental applications, wound healing, bone marrow transplants, spinal cord injuries, osteoarthritis, to name a few. For those of you that read OTW, Robin has his mom burning the midnight coal, pumping out as many press releases as she can about this industry. Hopefully, she will not develop carpal tunnel syndrome. Yet, as we all know, there are still many questions that need to be identified regarding the efficacy of mesenchymal stem cells. What we have learned after many years of research is that they can communicate actively and intimately. Safety issues play a role in terms of processing, concentration, and whom are you harvesting those MSC's from. If you had your options, most of us would desire to have our own stem cells harvested, processed and delivered in real time. I can hear the PRP people screaming, what about us!!! Unfortunately, TSB believes that their isn't enough of revenue in harvesting a patients own stem cells considering that one is only able to charge for the processing equipment, and processing takes time. On the other hand, allogenic stem cells, those little babies derived from a deceased donor and processed to ensure safety have become a viable alternative. But the big question surrounding allogenic stem cells is how many of those cells are viable? How many of those cells have survived the cleansing process? The difference between autogenous and allogenic is that the donors need to be screened and tested for bacteria and any infectious agents that may replicate themselves within the cells of a living host. There is always the risk of tissue mismatch or infection but in this day and age processing for infection has become a moot point. Harvesting MSC's from bone marrow and adipose seems to be the current state of the art, and God only knows that there are plenty of fat people in the United States that could use a little lip-o-suction. Cultured stem cells derived from living donors need certain conditions that promote self-regenerating expansion of undifferentiated progenitor into cells required for transplant. So in closing remember, that in order to meet therapeutic requirements MSC's need to go through six stages:
Not Harm the Recipient
As each year passes, more information is disseminated as to the efficacy of MSC's, but the question must be asked, at what price? Based on the current state of the economy, factoring in the many concerns that the healthcare industry has about escalating costs, will someone be able to deliver a product that will be cost effective? The immediate response is to compare it to INFUSE, unfortunately, that selling technique will no longer play in Peoria, and there are other viable options in the marketplace. So TSB wants to know are you coming or are you going?